Connect with us

International

4 Health Care Stocks To Watch As The FDA Talks Booster Shots

Health care stocks to consider as stocks seek direction despite positive earnings data.
The post 4 Health Care Stocks To Watch As The FDA Talks Booster Shots appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket….

Published

on

4 Top Health Care Stocks For Your Q4 Watchlist

In times of volatility in the stock market, investors often turn to health care stocks. For the most part, this could be the case now given the current movement in the market. On one hand, earnings season seems to be kicking off on a high. This is evident as industry giants such as Delta Air Lines (NYSE: DAL) and JPMorgan (NYSE: JPM) post solid figures. Arguably, these numbers would suggest that the economy is on the rise, given the cyclical-based nature of their businesses. On the other hand, supply chain pressures and inflation jitters continue to hang over the broader market as well. As such, some would argue that health care stocks could be worth watching in the stock market today.

Notably, there is also no shortage of news for investors to digest from the industry now as well. Like with most developments regarding the pandemic, booster shot news continues to put Moderna (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) in the limelight. With the FDA set to review the need for additional doses from these firms, this is not surprising. Elsewhere Jasper Therapeutics (NASDAQ: JSPR) is in a similar position as well. This would be mostly thanks to Oppenheimer (NYSE: OPY)analyst Jay Olson hitting JSPR stock with an Outperform rating. With all this activity in the space, could one of these players be top health care stocks to consider now?

Best Health Care Stocks To Watch Right Now

Ocugen Inc.

Ocugen is a biopharmaceutical company that is developing gene therapies to cure ocular diseases and also developing its coronavirus vaccine. By using its breakthrough modifier gene therapy platform, it has the potential to treat multiple retinal diseases with one drug. OCGN stock has shot up by over 25% since the start of the week. This latest rally could be due to investors responding positively to the company’s partner Bharat Biotech.

On Tuesday, India had recommended the emergency use of Bharat’s coronavirus vaccine shot in children below 12 years of age, making it the first vaccine maker in the country to get such an approval after a review of its trial data for the 2 to 18 age group. Named Covaxin, it is co-developed by both Ocugen and Bharat. It uses an inactivated coronavirus with an immunity booster and is among the three shots that are being used in India as part of the vaccination drive for adults. With that being said, should investors consider adding OCGN stock to their portfolios?

top health care stocks (OCGN stock)Sour
Source: TD Ameritrade TOS

Read More

Pfizer Inc.

Next up on this list of health care stocks, we have Pfizer. The company is a titan in the industry and has over 25,000 clinical researchers testing every day with pharmaceutical development and innovation at its focus. Also, its therapeutic areas include internal medicine, rare diseases, oncology, and vaccines among others. Impressively, it also boasts a pipeline of over 90 new pharmaceutical drugs at various clinical stages. Recently, The Wall Street Journal reported that Pfizer’s vaccine is the world’s preferred shot as countries from Latin America to the Middle East have all relied on the company for its vaccine.

In late September, the company announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has approved Cibinqo, an oral, once-daily Janus kinase 1 inhibitor. The drug will be used to treat moderate to severe atopic dermatitis in adults and adolescents aged 12 years and older with inadequate response to existing therapies.

“There have been limited treatment options available for moderate to severe atopic dermatitis and we’re hopeful for the positive impact CIBINQO may have on the lives of people in Japan living with this chronic and potentially debilitating disease,” said Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. The company also says that it will ensure that Cibinqo is routinely accessible to as many patients as possible. For these reasons, will you add PFE stock to your watchlist?

PFE stock chart
Source: TD Ameritrade TOS

[Read More] 4 Artificial Intelligence Stocks To Watch Right Now

UnitedHealth Group Inc.

Following that, we have UnitedHealth Group, a multinational managed health care and insurance company with headquarters in Minnesota. In essence, it is a diversified health care company that offers a broad spectrum of products and services through two distinct platforms. Namely, this would include UnitedHealthcare, which provides health care coverage and benefits services, and Optum, which provides information and technology-enabled health services.

On October 7, 2021, the company announced an innovative collaboration with SSM Health on making quality care more accessible and affordable to people across the Midwest. Accordingly, the companies will partner across functions like inpatient care management and digital transformation to improve health outcomes and patients’ health care experiences. Furthermore, the two companies will use clinical technologies, advanced analytic tools, and the delivery of data-driven insights at the point of care to improve health care needs. With this piece of information, is UNH stock worth watching right now?

best health care stocks (UNH stock)
Source: TD Ameritrade TOS

[Read More] Up And Coming Stocks To Buy Right Now? 3 Retail Stocks In Focus

Revance Therapeutics Inc.

Topping off our list today is Revance Therapeutics. In brief, the Tennessee-based biotech firm specializes in developing aesthetic and therapeutic offerings. Among its core products would be its next-generation neuromodulator, DaxibotulinumtoxinA (DA) for Injection. Through DA for Injection, Revance hopes to treat glabellar lines, vertical creases that develop between the eyebrows. Additionally, the company is also actively working with Viatris (NASDAQ: VTRS) to develop a “biosimilar” to Botox.

By and large, this could be due to its latest update on DA for Injection. Namely, Revance is currently pursuing a Biologics License Application (BLA) for DA from the FDA. Earlier today, the company reaffirmed its confidence in its BLA submission and anticipates FDA approval later this year. Should this be the case, it would mark a significant win for Revance.

Furthermore, the company also launched a first-of-its-kind “relational commerce platform” earlier this week, OPUL. With OPUL, Revance is looking to provide a one-stop digital destination for consumers in the growing aesthetic industry. According to Revance, the platform will also serve to foster “increased customer loyalty and retention” in the long run. Because of all this, could RVNC stock be worth keeping an eye on for you?

RVNC stock chart
Source: TD Ameritrade TOS

The post 4 Health Care Stocks To Watch As The FDA Talks Booster Shots appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

International

The next pandemic? It’s already here for Earth’s wildlife

Bird flu is decimating species already threatened by climate change and habitat loss.

I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.

I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.

This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.

How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.

This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.

This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.

H5N1 originated on a Chinese poultry farm in 1997. ChameleonsEye/Shutterstock

The first signs

Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.

We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.

Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.

Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.

Unfortunately, our warnings were correct.

A roving sickness

Two decades on, bird flu is killing species from the high Arctic to mainland Antarctica.

In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.

Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.

The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.

Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.

At the crossroads

Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.

Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.

It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.

Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.

Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.

A colony of king penguins.
Remote penguin colonies are already threatened by climate change. AndreAnita/Shutterstock

How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.

To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.

Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

International

This is the biggest money mistake you’re making during travel

A retail expert talks of some common money mistakes travelers make on their trips.

Published

on

Travel is expensive. Despite the explosion of travel demand in the two years since the world opened up from the pandemic, survey after survey shows that financial reasons are the biggest factor keeping some from taking their desired trips.

Airfare, accommodation as well as food and entertainment during the trip have all outpaced inflation over the last four years.

Related: This is why we're still spending an insane amount of money on travel

But while there are multiple tricks and “travel hacks” for finding cheaper plane tickets and accommodation, the biggest financial mistake that leads to blown travel budgets is much smaller and more insidious.

A traveler watches a plane takeoff at an airport gate.

Jeshoots on Unsplash

This is what you should (and shouldn’t) spend your money on while abroad

“When it comes to traveling, it's hard to resist buying items so you can have a piece of that memory at home,” Kristen Gall, a retail expert who heads the financial planning section at points-back platform Rakuten, told Travel + Leisure in an interview. “However, it's important to remember that you don't need every souvenir that catches your eye.”

More Travel:

According to Gall, souvenirs not only have a tendency to add up in price but also weight which can in turn require one to pay for extra weight or even another suitcase at the airport — over the last two months, airlines like Delta  (DAL) , American Airlines  (AAL)  and JetBlue Airways  (JBLU)  have all followed each other in increasing baggage prices to in some cases as much as $60 for a first bag and $100 for a second one.

While such extras may not seem like a lot compared to the thousands one might have spent on the hotel and ticket, they all have what is sometimes known as a “coffee” or “takeout effect” in which small expenses can lead one to overspend by a large amount.

‘Save up for one special thing rather than a bunch of trinkets…’

“When traveling abroad, I recommend only purchasing items that you can't get back at home, or that are small enough to not impact your luggage weight,” Gall said. “If you’re set on bringing home a souvenir, save up for one special thing, rather than wasting your money on a bunch of trinkets you may not think twice about once you return home.”

Along with the immediate costs, there is also the risk of purchasing things that go to waste when returning home from an international vacation. Alcohol is subject to airlines’ liquid rules while certain types of foods, particularly meat and other animal products, can be confiscated by customs. 

While one incident of losing an expensive bottle of liquor or cheese brought back from a country like France will often make travelers forever careful, those who travel internationally less frequently will often be unaware of specific rules and be forced to part with something they spent money on at the airport.

“It's important to keep in mind that you're going to have to travel back with everything you purchased,” Gall continued. “[…] Be careful when buying food or wine, as it may not make it through customs. Foods like chocolate are typically fine, but items like meat and produce are likely prohibited to come back into the country.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

As the pandemic turns four, here’s what we need to do for a healthier future

On the fourth anniversary of the pandemic, a public health researcher offers four principles for a healthier future.

John Gomez/Shutterstock

Anniversaries are usually festive occasions, marked by celebration and joy. But there’ll be no popping of corks for this one.

March 11 2024 marks four years since the World Health Organization (WHO) declared COVID-19 a pandemic.

Although no longer officially a public health emergency of international concern, the pandemic is still with us, and the virus is still causing serious harm.

Here are three priorities – three Cs – for a healthier future.

Clear guidance

Over the past four years, one of the biggest challenges people faced when trying to follow COVID rules was understanding them.

From a behavioural science perspective, one of the major themes of the last four years has been whether guidance was clear enough or whether people were receiving too many different and confusing messages – something colleagues and I called “alert fatigue”.

With colleagues, I conducted an evidence review of communication during COVID and found that the lack of clarity, as well as a lack of trust in those setting rules, were key barriers to adherence to measures like social distancing.

In future, whether it’s another COVID wave, or another virus or public health emergency, clear communication by trustworthy messengers is going to be key.

Combat complacency

As Maria van Kerkove, COVID technical lead for WHO, puts it there is no acceptable level of death from COVID. COVID complacency is setting in as we have moved out of the emergency phase of the pandemic. But is still much work to be done.

First, we still need to understand this virus better. Four years is not a long time to understand the longer-term effects of COVID. For example, evidence on how the virus affects the brain and cognitive functioning is in its infancy.

The extent, severity and possible treatment of long COVID is another priority that must not be forgotten – not least because it is still causing a lot of long-term sickness and absence.

Culture change

During the pandemic’s first few years, there was a question over how many of our new habits, from elbow bumping (remember that?) to remote working, were here to stay.

Turns out old habits die hard – and in most cases that’s not a bad thing – after all handshaking and hugging can be good for our health.

But there is some pandemic behaviour we could have kept, under certain conditions. I’m pretty sure most people don’t wear masks when they have respiratory symptoms, even though some health authorities, such as the NHS, recommend it.

Masks could still be thought of like umbrellas: we keep one handy for when we need it, for example, when visiting vulnerable people, especially during times when there’s a spike in COVID.

If masks hadn’t been so politicised as a symbol of conformity and oppression so early in the pandemic, then we might arguably have seen people in more countries adopting the behaviour in parts of east Asia, where people continue to wear masks or face coverings when they are sick to avoid spreading it to others.

Although the pandemic led to the growth of remote or hybrid working, presenteeism – going to work when sick – is still a major issue.

Encouraging parents to send children to school when they are unwell is unlikely to help public health, or attendance for that matter. For instance, although one child might recover quickly from a given virus, other children who might catch it from them might be ill for days.

Similarly, a culture of presenteeism that pressures workers to come in when ill is likely to backfire later on, helping infectious disease spread in workplaces.

At the most fundamental level, we need to do more to create a culture of equality. Some groups, especially the most economically deprived, fared much worse than others during the pandemic. Health inequalities have widened as a result. With ongoing pandemic impacts, for example, long COVID rates, also disproportionately affecting those from disadvantaged groups, health inequalities are likely to persist without significant action to address them.

Vaccine inequity is still a problem globally. At a national level, in some wealthier countries like the UK, those from more deprived backgrounds are going to be less able to afford private vaccines.

We may be out of the emergency phase of COVID, but the pandemic is not yet over. As we reflect on the past four years, working to provide clearer public health communication, avoiding COVID complacency and reducing health inequalities are all things that can help prepare for any future waves or, indeed, pandemics.

Simon Nicholas Williams has received funding from Senedd Cymru, Public Health Wales and the Wales Covid Evidence Centre for research on COVID-19, and has consulted for the World Health Organization. However, this article reflects the views of the author only, in his academic capacity at Swansea University, and no funding or organizational bodies were involved in the writing or content of this article.

Read More

Continue Reading

Trending